Table 2.
n (% of 33) | 95% CI | |
---|---|---|
Primary outcomes (after 1 month) | ||
Major bleeding | 12 (36) | 22–53 |
All-cause mortality | 16 (49) | 31–66 |
Secondary outcomes (after 3 months) | ||
All-cause mortality | 16 (50)a | 34–66 |
Recurrence of VTE | 1 (3)a | 1–16 |
Other outcomes | ||
Hospital length of stay (median days (IQR)) | 17 (10–30)b |
CI Confidence interval, IQR interquartile range, VTE venous thrombo-embolism
an = 32; bAssessed in all patients surviving the first month of follow-up